Understanding pharmacological complement inhibition in paroxysmal nocturnal hemoglobinuria

類似資料

• Polymorphism of the complement receptor 1 gene correlates with the hematologic response to eculizumab in patients with paroxysmal nocturnal hemoglobinuria
  著者:: Tommaso Rondelli, 等
  出版事項: (2014-02-01)
• Eculizumab for paroxysmal nocturnal hemoglobinuria: Two cases of successful pregnancy outcomes
  著者:: Jovanka Ilic, 等
  出版事項: (2024-05-01)
• Paroxysmal nocturnal hemoglobinuria and pregnancy before the eculizumab era: the French experience
  著者:: Sophie de Guibert, 等
  出版事項: (2011-09-01)
• Efficacy of iptacopan monotherapy for suboptimal response to eculizumab in patients with paroxysmal nocturnal hemoglobinuria
  著者:: Olesya U. Klimova, 等
  出版事項: (2025-01-01)
• Evaluation of hemostasis and endothelial function in patients with paroxysmal nocturnal hemoglobinuria receiving eculizumab
  著者:: Dominique Helley, 等
  出版事項: (2010-04-01)